Clinical Trials Directory

Trials / Completed

CompletedNCT02055729

Changes in Bacterial Flora Among Patients With Pelvic Bedsores: a Prospective Pilot Study

Changes in Cutaneous, Digestive and Urinary Bacterial Flora Among Patients With Pelvic Bedsores: a Prospective Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to characterize the evolution (over a period of 28 days) of superficial and deep bacterial skin flora in patients with stage 3 or 4 sacral pressure ulcers (bedsores). Changes in terms of pathogenic, potentially pathogenic and non-pathogenic bacterial species at the intra-individual and population levels.

Detailed description

The secondary objectives of this study are: A. To compare bacterial communities collected from superficial versus deep samples of stage 3 or 4 sacral bedsores using metagenomics and standard culturing methods. B. To characterize the evolution of digestive bacterial flora in the same patients over a period of 28 days. Changes in terms of pathogenic, potentially pathogenic and non-pathogenic will be described, as well as the appearance of resistance phenotypes. C. To characterize the evolution of urinary bacterial flora in the same patients over a period of 28 days. Changes in terms of pathogenic, potentially pathogenic and non-pathogenic will be described, as well as the appearance of resistance phenotypes.

Conditions

Interventions

TypeNameDescription
BIOLOGICAL3mm tissue punch biopsyBacterial samples will be collected using deep level tissue biopsy using a Steifel punch of 3 mm in diameter (days 0 and 28).
BIOLOGICALSuperficial bedsore sampleBacterial samples will be taken from the surface of the bedsore via swabbing. (days 0 \& 28)
BIOLOGICALStool sampleStool samples will be collected on days 0 and 28.
BIOLOGICALUrine sampleUrine samples will be collected on days 0 and 28.

Timeline

Start date
2015-05-11
Primary completion
2017-09-21
Completion
2017-09-21
First posted
2014-02-05
Last updated
2020-01-30

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02055729. Inclusion in this directory is not an endorsement.